Dose-Rate Variations for Patient Treatments in Flash and conventional radiation therapy
快速放射治疗和常规放射治疗中患者治疗的剂量率变化
基本信息
- 批准号:10290440
- 负责人:
- 金额:$ 22.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAddressBiologicalBiological ProcessBiologyChemicalsChemistryClinicalComplicationDependenceDoseDose-RateExternal Beam Radiation TherapyIntensity modulated proton therapyMapsMethodsModalityMonte Carlo MethodNormal tissue morphologyOutcomeOxygenPatientsPhotonsPhysicsPhysiologic pulsePlayPositioning AttributePrimary LesionProtonsQuality of lifeRadiation therapyReportingResearchRoleRotationScanningSpottingsStructureSystemTimeTissuesTranslationsTreatment ProtocolsWaterbasecancer therapyclinical practicedesignexperimental studyflexibilityimprovedinterestirradiationnanoscalenanosecondnext generationoptimal treatmentspatient variabilityproton therapyradiation responseside effectstandard caretime intervaltreatment effecttreatment planningtreatment sitetumor
项目摘要
Radiation therapy has been an important component in the treatment of cancer for many decades. While
the parameters of tumor control have been relatively well understood, normal tissue complication proba-
bilities (NTCPs) are often only thought of as constraining factors in the design of a treatment regimen.
However, with continuously improving treatments of primary lesions, NTCP and their impact on the
quality of life have moved into the focus of research.
One of the most prominent methods reported to spare healthy tissue is FLASH radiation therapy, i.e. ul-
trafast (>40 Gy/s) irradiations, which reportedly results in incredible tissue sparing effects without com-
promising efficacy for tumor cure. Conversely, very low dose-rate irradiations have also been reported
to offer protective features. Together, these experiments suggest that the current clinical routine, treating
patients with a medium dose-rate of ~2 Gy/min, could in fact be the least favorable when considering
healthy tissue side effects.
In clinical practice, patients are treated with a variety of radiation treatment modalities. While the result-
ing target doses are similar across modalities, the dose delivered to the normal tissue and the time struc-
ture of the delivery can vary significantly. Despite the range of dose-rates across treatment plans, the
biological effect is estimated only based on the total dose received.
We hypothesize that dose-rate plays an important role in the outcome of radiation therapy that can be
exploited for specific treatment scenarios. For extreme cases such as FLASH therapy, averaged dose-
rates do not capture the relevant time structures adequately. We will apply Monte Carlo simulations to
determine time structures from the clinical scale of minutes (spot scanning / gantry rotation time) to na-
noseconds (intra-spot delivery time) and assess potential effects on healthy tissue sparing that would im-
prove the quality of life for radiation therapy patients.
放射治疗是癌症治疗的一个重要组成部分,已经有几十年了。而
肿瘤控制的参数已经被相对较好地理解,正常组织并发症可能,
在治疗方案的设计中,NTCP通常仅被认为是限制因素。
然而,随着原发性病变治疗方法的不断改进,NTCP及其对
生活质量已经成为研究的焦点。
据报道,保护健康组织的最突出的方法之一是FLASH放射疗法,即ul-fuse放射疗法。
超快(>40戈伊/s)辐照,据报道,这会产生令人难以置信的组织保留效果,而不会出现并发症。
有希望的肿瘤治疗效果。相反,也有报道称,
以提供保护功能。总之,这些实验表明,目前的临床常规,治疗
中等剂量率约2戈伊/min的患者,实际上可能是最不利的,
健康组织的副作用
在临床实践中,患者采用各种放射治疗方式进行治疗。结果-
在不同的治疗方式中,靶向剂量相似,输送到正常组织的剂量和时间结构相似。
递送的真实性可以显著变化。尽管治疗计划的剂量率范围不同,
生物效应仅根据接受的总剂量进行估计。
我们假设剂量率在放射治疗的结果中起着重要的作用,
用于特定的治疗方案。对于极端情况,如FLASH治疗,平均剂量-
费率没有充分反映相关的时间结构。我们将应用蒙特卡罗模拟,
确定从分钟(点扫描/机架旋转时间)到NA的临床标度的时间结构,
noseconds(点内输送时间),并评估对健康组织保护的潜在影响,
证明放射治疗患者的生活质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jan Patrick Oscar Schuemann其他文献
Jan Patrick Oscar Schuemann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jan Patrick Oscar Schuemann', 18)}}的其他基金
Using experimentally-guided multi-scale modeling to determining the mechanism of FLASH tissue sparing
使用实验引导的多尺度建模来确定 FLASH 组织保留的机制
- 批准号:
10697374 - 财政年份:2022
- 资助金额:
$ 22.36万 - 项目类别:
Dose-Rate Variations for Patient Treatments in Flash and conventional radiation therapy
快速放射治疗和常规放射治疗中患者治疗的剂量率变化
- 批准号:
10405553 - 财政年份:2021
- 资助金额:
$ 22.36万 - 项目类别:
TOPAS - nBio, a Monte Carlo tool for radiation biology research
TOPAS - nBio,用于辐射生物学研究的蒙特卡罗工具
- 批准号:
8886436 - 财政年份:2015
- 资助金额:
$ 22.36万 - 项目类别:
TOPAS - nBio, a Monte Carlo tool for radiation biology research
TOPAS - nBio,用于辐射生物学研究的蒙特卡罗工具
- 批准号:
10331855 - 财政年份:2015
- 资助金额:
$ 22.36万 - 项目类别:
TOPAS - nBio, a Monte Carlo tool for radiation biology research
TOPAS - nBio,用于辐射生物学研究的蒙特卡罗工具
- 批准号:
9886932 - 财政年份:2015
- 资助金额:
$ 22.36万 - 项目类别:
TOPAS - nBio, a Monte Carlo tool for radiation biology research
TOPAS - nBio,用于辐射生物学研究的蒙特卡罗工具
- 批准号:
9234495 - 财政年份:2015
- 资助金额:
$ 22.36万 - 项目类别:
TOPAS - nBio, a Monte Carlo tool for radiation biology research
TOPAS - nBio,用于辐射生物学研究的蒙特卡罗工具
- 批准号:
10837209 - 财政年份:2015
- 资助金额:
$ 22.36万 - 项目类别:
TOPAS - nBio, a Monte Carlo tool for radiation biology research
TOPAS - nBio,用于辐射生物学研究的蒙特卡罗工具
- 批准号:
10559566 - 财政年份:2015
- 资助金额:
$ 22.36万 - 项目类别:
相似海外基金
Systems modeling to address the social and biological drivers of disparities in infection and mortality from emerging infectious diseases
用于解决新发传染病感染和死亡率差异的社会和生物驱动因素的系统建模
- 批准号:
10669177 - 财政年份:2022
- 资助金额:
$ 22.36万 - 项目类别:
Systems modeling to address the social and biological drivers of disparities in infection and mortality from emerging infectious diseases
用于解决新发传染病感染和死亡率差异的社会和生物驱动因素的系统建模
- 批准号:
10415713 - 财政年份:2022
- 资助金额:
$ 22.36万 - 项目类别:
Transporting established insights from classical experimental design to address causal questions in environmental epidemiology including the understanding of biological mediating mechanisms
运用经典实验设计的既定见解来解决环境流行病学中的因果问题,包括对生物介导机制的理解
- 批准号:
10395286 - 财政年份:2021
- 资助金额:
$ 22.36万 - 项目类别:
Advancing cryo-EM technology to address difficult biological questions
推进冷冻电镜技术解决棘手的生物学问题
- 批准号:
10570241 - 财政年份:2021
- 资助金额:
$ 22.36万 - 项目类别:
Advancing cryo-EM technology to address difficult biological questions
推进冷冻电镜技术解决棘手的生物学问题
- 批准号:
10166355 - 财政年份:2021
- 资助金额:
$ 22.36万 - 项目类别:
Advancing cryo-EM technology to address difficult biological questions
推进冷冻电镜技术解决棘手的生物学问题
- 批准号:
10376252 - 财政年份:2021
- 资助金额:
$ 22.36万 - 项目类别:
Building Infrastructure to Address Social, Cultural and Biological Determinants of Diabetes in Lebanon
建设基础设施以解决黎巴嫩糖尿病的社会、文化和生物决定因素
- 批准号:
10237378 - 财政年份:2020
- 资助金额:
$ 22.36万 - 项目类别:
Reprogramming genetic information at the RNA level: optimizing tools to address specific biological questions
在 RNA 水平上重新编程遗传信息:优化工具来解决特定的生物学问题
- 批准号:
404867268 - 财政年份:2018
- 资助金额:
$ 22.36万 - 项目类别:
Priority Programmes
Biological soil crusts as unique microecosystem represent a suitable model system to address taxonomy and cryptic diversity of microalgal key players
生物土壤结皮作为独特的微生态系统,代表了解决微藻关键参与者的分类学和神秘多样性的合适模型系统
- 批准号:
350173788 - 财政年份:2017
- 资助金额:
$ 22.36万 - 项目类别:
Priority Programmes
Multidisciplinary translational research to address social disparities in osteoporosis: Understanding the social context of biological mechanisms
解决骨质疏松症社会差异的多学科转化研究:了解生物机制的社会背景
- 批准号:
nhmrc : 1107510 - 财政年份:2016
- 资助金额:
$ 22.36万 - 项目类别:
Career Development Fellowships